post op pain management

  • 文章类型: Journal Article
    尽管研究表明,只有不到一半的手术患者报告术后疼痛得到有效缓解,大多数患者忍受急性术后不适。为了减轻和控制术后疼痛,各种术前,术中,术后治疗和管理方法可用。几年来,一种名为丁丙诺啡的阿片类药物已成为治疗许多不同人口统计学患者阿片类药物使用障碍(OUD)的有效工具。然而,它在治疗慢性疼痛或术后疼痛的患者时可以看到它的使用障碍,他们也有一个OUD。虽然丁丙诺啡在临床环境中可能未得到充分利用,使用该药物时慢性滥用率明显较低,因此对患者来说是一种有吸引力的治疗选择。本文旨在探索广泛的研究,以检查丁丙诺啡作为镇痛药以及如何将其用于术前疼痛和术后疼痛。本文将对丁丙诺啡及其在慢性疼痛和OUD患者中的应用进行深入分析。通过数据库PubMed识别研究进行了系统的文献综述。收集了来自各种出版物的数据,并优先考虑了过去三年内的出版物。我们回顾了研究丁丙诺啡后患者疼痛程度的研究。尽管有长期的药理学证据和临床研究,丁丙诺啡作为镇痛药一直保持神秘感。与其他阿片类药物相比,其在OUD治疗中的使用进一步受到其众所周知的安全益处和相对缺乏精神模拟副作用的影响。对于长期习惯的患者,高剂量阿片类药物可能正在经历痛觉过敏,但没有被医生告知这种现象或丁丙诺啡解决它的潜力,丁丙诺啡明显的抗痛觉过敏作用是一个引人注目的药理学特征,使其作为一种选择特别有吸引力。当在预使用时,pery-,和术后情况,丁丙诺啡提供各种疼痛管理益处,患者仍可从mu-阿片激动剂的有效疼痛管理中获益,同时仍继续服用丁丙诺啡.丁丙诺啡可以根据需要以减少的剂量继续使用,以避免戒断症状并根据现有证据提高与急性术后疼痛联合使用的mu-阿片激动剂的镇痛效率。丁丙诺啡给药需要以患者为中心,多学科策略,考虑了许多围手术期治疗方案的利弊,以获得最大的成功机会。
    Although research suggests that less than half of individuals who have surgical procedures report effective postoperative pain alleviation, the majority of patients endure acute postoperative discomfort. To lessen and manage postoperative pain, a variety of preoperative, intraoperative, and postoperative treatments and management methods are available. For several years an opioid called buprenorphine has become an effective tool to treat opioid use disorder (OUD) in patients across many different demographics. It has however endured barriers to its usage which can be seen when treating patients with chronic pain or postoperative pain, who also have an OUD. While buprenorphine may be underutilized within the clinical setting, the significantly low rates of chronic abuse when using the drug allow it to be an attractive treatment option for patients. This paper aims to explore a wide range of studies that examine buprenorphine as an analgesic and how it can be used for preoperative pain and postoperative pain. This paper will give an in-depth analysis of buprenorphine and its use in patients with chronic pain as well as OUD. A systematic literature review was performed by identifying studies through the database PubMed. The data from various publications were gathered with preference being given to publications within the last three years. We reviewed studies that examined the pain level of the patients after having buprenorphine. Despite long-available pharmacologic evidence and clinical research, buprenorphine has maintained a mystique as an analgesic. Its usage in the treatment of OUD was further influenced by its well-known safety benefits and relative lack of psychomimetic side effects compared to other opioids. For patients accustomed to long-term, high-dose opioids who may be experiencing hyperalgesia but have not been informed about this phenomenon by their doctors or the potential for buprenorphine to resolve it, buprenorphine\'s pronounced antihyperalgesic effect is a compelling pharmacologic characteristic that makes it particularly attractive as an option. When used in pre-, peri-, and postoperative circumstances, buprenorphine provides various pain-management benefits and patients can still benefit from effective pain management from mu-opioid agonists while remaining on buprenorphine. Buprenorphine can be continued at a reduced dose as needed to avoid withdrawal symptoms and to improve the analgesic efficiency of mu-opioid agonists used in combination with acute postoperative pain in light of the evidence at hand. Buprenorphine administration needs a patient-centered, multidisciplinary strategy that considers the benefits and drawbacks of the many perioperative therapy options to have the best chance of success.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

  • 文章类型: Journal Article
    全膝关节置换术(TKA)患者对术后疼痛管理的舒适度最低。使用肠胃外阿片类药物或硬膜外镇痛可能会产生不利的不利影响,从而干扰快速愈合和康复。不确定关节周围多模式药物注射(PMDI)是否有效缓解全膝关节或全髋关节置换术(THA)后的疼痛。我们进行了这项研究,以评估TKA或THA后PMDI的有效性。文章的来源是使用Pubmed上的以下关键字,谷歌学者,和WebofScience:全膝关节置换术或髋关节置换术中的多模式药物鸡尾酒,关节周围注射和多模式药物鸡尾酒,硬膜外与关节周围注射和全关节置换术后疼痛管理。在筛选438篇文章和摘要后,发现了200项相关研究,其中共有10篇文章被纳入研究。从这篇评论来看,我们想得出结论,尽管有各种方法来解决术后疼痛,目前尚无公认的全关节置换术后疼痛管理金标准.为了减少麻醉品的摄入量并防止与麻醉品有关的不良反应,利用区域麻醉药的多模式技术似乎正在上升,如关节周围注射,或有或没有股神经阻滞的患者自控镇痛。即使理想的持续时间和药物种类尚不清楚,术前疼痛管理或使用抗炎药物和阿片类镇痛药进行超前镇痛似乎有助于减轻术后疼痛.
    Total knee arthroplasty (TKA) patients express minimal comfort regarding postoperative pain management. The use of parenteral opioids or epidural analgesia may have unfavorable adverse impacts that interfere with quick healing and rehabilitation. It is uncertain if periarticular multimodal drug injections (PMDI) are effective at easing pain following total knee or total hip arthroplasty (THA). We conducted this study to assess the effectiveness of PMDI following TKA or THA. Articles were sourced using the following keywords on Pubmed, Google scholar, and the Web of Science: multimodal drug cocktail in total knee arthroplasty OR hip arthroplasty, periarticular injections AND multimodal drug cocktail, epidural versus periarticular injections AND pain management after total joint arthroplasty. After screening 438 articles and abstracts, 200 pertinent studies were found, of which a total of 10 articles were included in the study. From this review, we want to conclude that despite the various ways to address postoperative pain, there is no acknowledged gold standard for postoperative pain management following total joint arthroplasty. To reduce narcotic intake and prevent narcotic-related adverse reactions, multimodal techniques utilizing regional anesthetics appear to be on the rise such as periarticular injections, or patient-controlled analgesia with or without femoral nerve block. Even though the ideal duration and kind of medications are unclear, preoperative pain management or preemptive analgesia with anti-inflammatory drugs and opioid analgesics seem to be useful in lowering postoperative pain.
    导出

    更多引用

    收藏

    翻译标题摘要

    我要上传

       PDF(Pubmed)

公众号